Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velusetrag in chronic constipation
NCT00391820Phase 2Completed
- Sponsor
- Alfasigma
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of velusetrag in chronic constipation (4 arms), sponsored by Alfasigma. Primary endpoint: Clinical response. Started Oct 2006; status: completed.
02
Drugs
velusetrag
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00391820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391820.